US2004166566A1PendingUtilityA1
Novel promoter
Priority: Jun 6, 2001Filed: Jun 5, 2002Published: Aug 26, 2004
Est. expiryJun 6, 2021(expired)· nominal 20-yr term from priority
C12N 15/70C12N 15/71C12P 21/02C12N 15/67C07K 14/245
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates a promoter capable of strongly expressing a gene linked downstream (3′ side) of the promoter in prokaryote, especially in Escherichia Coli . The promoter of the invention is a promoter for prokaryote having a novel nucleotide sequence between any −35 region sequence and any −10 region sequence. The promoter has a strong promoter activity and thus a target peptide or protein can be produced at a high efficiency and in large amounts through linking the structural gene encoding the target peptide or protein downstream of the promoter.
Claims
exact text as granted — not AI-modified1 . A promoter comprising the same or substantially the same nucleotide sequence as that shown by SEQ ID NO: 34.
2 . The promoter according to claim 1 , which comprises the same or substantially the same nucleotide sequence as that shown by SEQ ID NO: 34 between any type of −35 region and any type of −10 region.
3 . The promoter according to claim 2 , in which the −35 region has the nucleotide sequence shown by SEQ ID NO: 37.
4 . The promoter according to claim 2 , in which the −10 region has the nucleotide sequence shown by SEQ ID NO: 38 or 39.
5 . The promoter according to claim 2 , which has the nucleotide sequence shown by SEQ ID NO: 35.
6 . The promoter according to claim 2 , which has the nucleotide sequence shown by SEQ ID NO: 36.
7 . A DNA comprising the promoter according to any one of claims 1 to 6 .
8 . A recombinant vector comprising the promoter according to any one of claims 1 to 6 or the DNA according to claim 7 .
9 . The recombinant vector according to claim 8 , which comprises a DNA having a structural gene to be expressed under the control of the promoter according to any one of claims 1 to 6 .
10 . The recombinant vector according to claim 9 , referred to as pNP3GHNO12, in which the structural gene is the human gorwth hormone gene.
11 . A transformant transformed with the recombinant vector according to claim 9 .
12 . The transformant Escherichia coli MM294/pNP3GHNO12 (FERM BP-7611), which is transformed with the the recombinant vector according to claim 10 .
13 . A method of producing a protein or a salt thereof, which comprises culturing the transformant according to claim 11 to produce the protein encoded by the structural gene.
14 . A method of producing the human growth hormone or a salt thereof, which comprises culturing the transformant according to claim 12 to produce the human growth hormone.
15 . The recombinant vector according to claim 9 , in which the structural gene is a reporter gene.
16 . The recombinant vector according to claim 15 , in which the reporter gene is kanamycin resistance gene or GFP gene.
17 . A transformant transformed with the recombinant vector according to claim 15 .
18 . A transformant transformed with the recombinant vector according to claim 16 .
19 . A DNA comprising the same or substantially the same nucleotide sequence as that shown by SEQ ID NO: 34.
20 . The DNA according to claim 20 , which comprises the same or substantially the same nucleotide sequence as that shown by SEQ ID NO: 34 between any type of −35 region and any type of −10 region.
21 . Use of the DNA according to claim 19 or 20 for the production of a promoter.
22 . Use of the promoter according to any one of claims 1 to 6 for the production of a protein encoded by a structural gene.Join the waitlist — get patent alerts
Track US2004166566A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.